Health Trials

HR+/HER2- Advanced/Metastatic Breast Cancer

1

Review clinical trials related to HR+/HER2- Advanced/Metastatic Breast Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Sirolimus for Injection (Albumin-bound) Combined With Fulvestrant for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Previously Treated With CDK4/6 Inhibitors

A randomized, double-blind, multicenter phase III clinical study to evaluate the efficacy and safety of sirolimus for injection (albumin-bound) combined with fulvestrant in patients with HR+ and HER2- advanced breast cancer.

Participants needed: 312
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Updated: Apr 16, 2025Locations: 1
Eligibility criteria

1. Aged 18 or above, regardless of gender; female patients must be postmenopausa... [+11]

1. Previous pathological diagnosis of HER2-positive breast cancer. [+20]

Read more